Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

1998

Chadburn A, Chen JM, Hsu DT, Frizzera G, Cesarman E, Garrett TJ, et al. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer. 1998;82(10):1978-87.

Sanchez T, Moreno JJ. Induction by interleukin-1beta peptide of prostaglandin E2 formation via enhanced prostaglandin H synthase-2 expression in 3T6 fibroblasts. Biochem Pharmacol. 1998;56(6):759-61.

Flore O, Rafii S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature. 1998;394(6693):588-92.

Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, et al. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. J Heart Lung Transplant. 1998;17(12):1161-6.

Humar A, Jessurun J, Sharp HL, Gruessner RW. Thrombotic microangiopathy after liver-small bowel transplant. Clin Transplant. 1998;12(6):600-1.

Bao L, Loda M, Zetter BR. Thymosin beta15 expression in tumor cell lines with varying metastatic potential. Clin Exp Metastasis. 1998;16(3):227-33.

Magro CM, Crowson AN, Schapiro BL. The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol. 1998;25(2):72-8.

Yang RM, Naitoh J, Murphy M, Wang HJ, Phillipson J, deKernion JB, et al. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J Urol. 1998;159(3):941-5.

Yang M, Loda M, Sytkowski AJ. Identification of genes expressed differentially by LNCaP or PC-3 prostate cancer cell lines. Cancer Res. 1998;58(16):3732-5.

Champliaud MF, Champliaud D, Albalat R, Burgeson R, Magro C, Baden HP. Localization and characterization of the RNA binding protein TLS in skin and stratified mucosa. J Invest Dermatol. 1998;110(3):277-81.